Furthermore, MAFG-AS1 knockdown may inhibit the proliferation, migration, invasion, and tumor growth of sorafenib-resistant HCC cells in vitro, suggesting the potential role of MAFG-AS1 in tumor-promoting drug resistance. This evidence concerns the gene MAFG and neoplasm.